Camila González Barral
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Camila González Barral has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Guénolé Fiche
Naver Labs Europe
1 shared publication - Laurent Servais
University of Oxford
1 shared publication - Renaud Seguier
CentraleSupélec, IETR (UMR CNRS 6164), France
1 shared publication - Simon Leglaive
CentraleSupélec, IETR (UMR CNRS 6164), France
1 shared publication - Vincent Sevestre
Centrale Nantes, France
1 shared publication
Latest Publications
- Open Access
- 8 December 2024
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 13 (1) , 77-85
Digital outcome measures in Duchenne muscular dystrophy: Lessons learnt from clinical trials
Duchenne muscular dystrophy is a severe neuromuscular disorder characterized by progressive muscle degeneration resulting from mutations in the dystrophin gene. Digital outcome measures offer a promising alternative to traditional outcome measures used in clinical trials. This review explores the development and application of digital outcome measures in Duchenne muscular dystrophy, emphasizing the feasibility, reliability, sensitivity, and validity of these measures. The stride velocity 95th centile has been validated as a robust endpoint and has been approved for use in clinical evaluation of drugs for the treatment of Duchenne muscular dystrophy by the European Medicines Agency. Although digital outcome measures have the potential to enhance the efficiency and accuracy of clinical trials, challenges such as limited sample sizes and patient compliance persist. The integration of artificial intelligence into the data analysis is in progress, but further validation is required before these analysis strategies can be incorporated into future clinical trial methodologies.
- 8 December 2024
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 13 (1) , 77-85
Open AccessDigital outcome measures in Duchenne muscular dystrophy: Lessons learnt from clinical trials
Duchenne muscular dystrophy is a severe neuromuscular disorder characterized by progressive muscle degeneration resulting from mutations in the dystrophin gene. Digital outcome measures offer a promising alternative to traditional outcome measures used in clinical trials. This review explores the development and application of digital outcome measures in Duchenne muscular dystrophy, emphasizing the feasibility, reliability, sensitivity, and validity of these measures. The stride velocity 95th centile has been validated as a robust endpoint and has been approved for use in clinical evaluation of drugs for the treatment of Duchenne muscular dystrophy by the European Medicines Agency. Although digital outcome measures have the potential to enhance the efficiency and accuracy of clinical trials, challenges such as limited sample sizes and patient compliance persist. The integration of artificial intelligence into the data analysis is in progress, but further validation is required before these analysis strategies can be incorporated into future clinical trial methodologies.
- Open Access
- 15 November 2023
- Published by Association for Computing Machinery (ACM)
- p. 1-7
SwimXYZ: A large-scale dataset of synthetic swimming motions and videos
Technologies play an increasingly important role in sports and become a real competitive advantage for the athletes who benefit from it. Among them, the use of motion capture is developing in various sports to optimize sporting gestures. Unfortunately, traditional motion capture systems are expensive and constraining. Recently developed computer vision-based approaches also struggle in certain sports, like swimming, due to the aquatic environment. One of the reasons for the gap in performance is the lack of labeled datasets with swimming videos. In an attempt to address this issue, we introduce SwimXYZ, a synthetic dataset of swimming motions and videos. SwimXYZ contains 3.4 million frames annotated with ground truth 2D and 3D joints, as well as 240 sequences of swimming motions in the SMPL parameters format. In addition to making this dataset publicly available, we present use cases for SwimXYZ in swimming stroke clustering and 2D pose estimation.
- 15 November 2023
- Published by Association for Computing Machinery (ACM)
- p. 1-7
Open AccessSwimXYZ: A large-scale dataset of synthetic swimming motions and videos
Technologies play an increasingly important role in sports and become a real competitive advantage for the athletes who benefit from it. Among them, the use of motion capture is developing in various sports to optimize sporting gestures. Unfortunately, traditional motion capture systems are expensive and constraining. Recently developed computer vision-based approaches also struggle in certain sports, like swimming, due to the aquatic environment. One of the reasons for the gap in performance is the lack of labeled datasets with swimming videos. In an attempt to address this issue, we introduce SwimXYZ, a synthetic dataset of swimming motions and videos. SwimXYZ contains 3.4 million frames annotated with ground truth 2D and 3D joints, as well as 240 sequences of swimming motions in the SMPL parameters format. In addition to making this dataset publicly available, we present use cases for SwimXYZ in swimming stroke clustering and 2D pose estimation.